Quantitative Mass Spectrometry Identifies Drug Targets in Cancer Stem Cell-Containing Side Population
- 18 September 2008
- journal article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 26 (12), 3037-3046
- https://doi.org/10.1634/stemcells.2008-0397
Abstract
A multifaceted approach is presented as a general strategy to identify new drug targets in a breast cancer stem cell-containing side population. The approach we have utilized combines side population cell sorting and stable isotope labeling by amino acids in cell culture with mass spectrometry to compare and identify proteins with differential expression profiles between side population cells, know to be enriched in cancer stem cells, and nonside population cells, which are depleted in cancer stem cells, for two breast cancer cell lines, MCF7 and MDA-MB231. Almost 900 proteins were quantified, and several important proteins in cell cycle control and differentiation were found to be upregulated in the cancer stem cell-containing side population. Most interestingly, a splice isoform of pyruvate kinase M2 as well as peroxiredoxin 6 were found to be downregulated. The differential levels of three of these proteins, thymosin β4 (TB4), proliferation-associated protein 2G4, and SIAH-interacting protein, were validated using Western blot. Furthermore, functional validation provided clear evidence that elevated TB4 expression contributes to drug resistance in the stem cell population. Small interfering RNA silencing of TB4 led to a loss of chemoresistance in two separate breast cancer populations. These proteins likely contribute to resistance in the cancer stem cell-containing side population, and their altered expression in a tumor causes clinical resistance to chemotherapy. The ability to perform quantitative mass spectrometry has enabled the identification of a series of proteins that could serve as future therapeutic targets. Disclosure of potential conflicts of interest is found at the end of this article.Keywords
This publication has 48 references indexed in Scilit:
- Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapyBreast Cancer Research, 2008
- A quantitative analysis software tool for mass spectrometry–based proteomicsNature Methods, 2008
- Identification of the functional role of peroxiredoxin 6 in the progression of breast cancerBreast Cancer Research, 2007
- Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesisNature Reviews Cancer, 2007
- Relative Quantification of Stable Isotope Labeled Peptides Using a Linear Ion Trap-Orbitrap Hybrid Mass SpectrometerAnalytical Chemistry, 2007
- Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometryNature Methods, 2007
- Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessProceedings of the National Academy of Sciences of the United States of America, 2006
- Strategies to eliminate cancer stem cells: Clinical implicationsEuropean Journal Of Cancer, 2006
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.The Journal of Experimental Medicine, 1996